Cargando…
Association between High On-Aspirin Platelet Reactivity and Reduced Superoxide Dismutase Activity in Patients Affected by Type 2 Diabetes Mellitus or Primary Hypercholesterolemia
Platelet hyperactivation is involved in the established prothrombotic condition of metabolic diseases such as Type 2 Diabetes Mellitus (T2DM) and familial hypercholesterolemia (HC), justifying the therapy with aspirin, a suppressor of thromboxane synthesis through the irreversible inhibition of cycl...
Autores principales: | Barale, Cristina, Cavalot, Franco, Frascaroli, Chiara, Bonomo, Katia, Morotti, Alessandro, Guerrasio, Angelo, Russo, Isabella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404318/ https://www.ncbi.nlm.nih.gov/pubmed/32679712 http://dx.doi.org/10.3390/ijms21144983 |
Ejemplares similares
-
Simvastatin Effects on Inflammation and Platelet Activation Markers in Hypercholesterolemia
por: Barale, Cristina, et al.
Publicado: (2018) -
Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation
por: Barale, Cristina, et al.
Publicado: (2017) -
Platelet Redox Imbalance in Hypercholesterolemia: A Big Problem for a Small Cell
por: Morotti, Alessandro, et al.
Publicado: (2022) -
High Glucose Inhibits the Aspirin-Induced Activation of the Nitric Oxide/cGMP/cGMP-Dependent Protein Kinase Pathway and Does Not Affect the Aspirin-Induced Inhibition of Thromboxane Synthesis in Human Platelets
por: Russo, Isabella, et al.
Publicado: (2012) -
Cardioprotective Properties of Human Platelets Are Lost in Uncontrolled Diabetes Mellitus: A Study in Isolated Rat Hearts
por: Russo, Isabella, et al.
Publicado: (2018)